Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI  by Roemer, F.W. et al.
Osteoarthritis and Cartilage 18 (2010) 1269e1274Anatomical distribution of synovitis in knee osteoarthritis and its association
with joint effusion assessed on non-enhanced and contrast-enhanced MRI
F.W. Roemer yz*, M. Kassim Javaid k{, A. Guermazi y, M. Thomas#, A. Kiran{,
R. Keen xyy, L. King#, N.K. Arden{#
yQuantitative Imaging Center (QIC), Department of Radiology, Boston University Medical Center, Boston, MA, USA
zDepartment of Radiology, Klinikum Augsburg, Augsburg, Germany
xUniversity College London Hospitals, London, UK
kNufﬁeld Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
{NIHR Biomedical Research Unit, University of Oxford, Nufﬁeld Orthopaedic Centre, Oxford, UK
#MRC Epidemiology Resource Centre, University of Southampton, UK
yy The Royal National Orthopaedic Hospital, Stanmore, UKa r t i c l e i n f o
Article history:
Received 17 December 2009
Accepted 20 July 2010
Keywords:
Osteoarthritis
Knee
MRI
Gadolinium
Effusion
Synovitis
Distribution* Address correspondence and reprint requests to:
Radiology, Boston University Medical Center, FGH Bui
Ave, Boston, MA 02118, USA. Tel: 1-617-414-3893; Fa
E-mail address: froemer@bu.edu (F.W. Roemer).
1063-4584/$ e see front matter  2010 Osteoarthriti
doi:10.1016/j.joca.2010.07.008s u m m a r y
Purpose: To describe the anatomical distribution of synovitis and its association with joint effusion on
non-enhanced and contrast-enhanced (CE) MRI in patients with knee osteoarthritis (OA).
Methods: Baseline MRI was performed at 1.5 T using axial proton density (PD)-weighted (w) fat sup-
pressed (fs) and axial and sagittal T1-w fs CE sequences. Synovial enhancement was scored in nine
articular subregions. Maximum synovial enhancement was grouped as absent (0), equivocal (1) and
deﬁnite (2 and 3). Effusion was scored from 0 to 3 on the axial sequences. We described the anatomical
distribution of synovitis, its association with effusion and compared assessment of effusion on T1-w fs CE
and PD fs sequences.
Results: 111 subjects were included and examined by MRI. 89.2% of knees exhibited at least one subregion
with a minimum grade 2 and 39.6% at the maximum of a grade 3. The commonest sites for deﬁnite
synovitis were posterior to the posterior cruciate ligament (PCL) in 71.2% and in the suprapatellar region
in 59.5% of all knees. On T1-w fs CE, 73.0% of knees showed any effusion. Deﬁnite synovitis in at least one
location was present in 96.3% knees with an effusion and in 70.0% without an effusion. Higher grades of
effusion were scored on the PD fs sequence.
Conclusion: Deﬁnite synovitis was present in the majority of knees with or without effusion with the
commonest sites being posterior to the PCL and in the suprapatellar recess. Joint effusion as measured on
PD fs images does not only represent effusion but also synovial thickening.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritic joints regularly exhibit signs of synovial activa-
tion even in the early phase of the disease1e5. Synovial activation in
osteoarthritis (OA) is reﬂected as synovitis and joint effusion on
magnetic resonance imaging (MRI). The amount of synovitis
appears to correlate with pain and may be a marker of structural
change and clinical outcome6,7. The histological correlates of
synovitis include synovial hyperplasia, ﬁbrosis, thickening of theF.W. Roemer, Department of
lding, 3rd ﬂoor, 820 Harrison
x: 1-617-638-6616.
s Research Society International. Psynovial capsule, activated synoviocytes and in some cases
lymphocytic inﬁltrates8.
To date, semi-quantitative MRI assessment of synovitis in large
studies of OA is usually performed on non-enhanced ﬂuid-sensitive
fat suppressed (fs) sequences9e11. Commonly, signal alterations in
Hoffa’s fat pad are scored as synovitis surrogates11,12, which have
shown an association with pain severity, but have proven to
represent only a non-speciﬁc marker when using contrast-
enhanced (CE) MRI as the reference standard13. This seems to be
supported by a recent comparative study including histology that
found only scoring of T1-weighted contrast-enhanced (T1-w CE)
images correlated with microscopically proven synovitis14. Conse-
quently, synovitis in osteoarthritic knees should probably be
assessed on T1-w CE sequences, which allow evaluation of
enhancement and thickening of the synovial membrane15e17.ublished by Elsevier Ltd. All rights reserved.
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tiation between synovium and joint effusion is only possible on CE
images and that ﬂuid-sensitive images seem to over-estimate
the amount of intraarticular ﬂuid18, which is the rationale why
some of the available semi-quantitative scoring systems of knee OA
suggest a combined synovitis/effusion score for assessing these
features on non-enhanced images9. Reliable instruments have been
introduced recently that are able to assess synovitis in a semi-
quantitative fashion at multiple sites within the knee joint on CE
images as the site of synovial inﬂammation seems to be of clinical
relevance19.
To date, it is not known if synovitis is distributed in a homoge-
neous fashion within the joint or if there are certain anatomical
subregions that are affected to a higher degree possibly due to other
concomitant intraarticular pathology. Thus, aim of our study was to
describe the anatomical distribution patterns of synovial
enhancement within the joint cavity and presence of joint effusion
in patients with radiographic knee OA based on a comprehensive
semi-quantitative scoring system using CE MRI. We further wished
to analyze if the amount of joint effusion may be assessed inter-
changeably on the ﬂuid-sensitive proton density (PD)-w sequence
when compared to the T1-w CE sequence.
Material and methods
Subjects
Subjects included in the present analysis were participants of
the VIDEO study a double-blind randomized interventional trial of
knee OA investigating the symptomatic and structural effects of
oral Vitamin D supplementation in participants with knee OA. OA
was deﬁned by presence of pain in one knee on most days in the
previous month and presence of at least one equivocal osteophyte
in the tibio-femoral (TF) compartment [KellgeneLawrence (K/L)
grade 1].
Patients were recruited through hospital-based clinics, primary
care and advertisement in local newspapers. Patients were eligible
if aged over 50 years, suffered pain in at least one knee for most
days of the previous month, had radiographic evidence of an
equivocal osteophyte in the same knee, were ambulatory (i.e., not
wheel chair bound) and were able and willing to attend or comply
with treatment and follow-up. Patients were excluded if they had
secondary OA, septic arthritis, gout, Wilson’s disease, Paget’s
disease, pseudo-gout, a history of inﬂammatory arthritis or knee
stiffness >30 min duration. Further exclusion criteria were current
use of cod liver oil or vitamin supplementation with a total
Vitamin D content greater than 200 IU, current use of glucosamine
or chondroitin for less than 3 months, history of hyperparathy-
roidism or osteomalacia, current use of anti-epileptic medication,
current use of bisphosphonates or use within the last 2 years,
history of hypercalcaemia, hypercalciuria, hyperthyroidism,
sarcoidosis, renal stones, previous intraarticular injections of
steroid within the last 3 months, hyalganwithin the last 6 months,
previous knee surgery or arthroscopy within the last 6 months,
history of an osteoporotic fracture, history of cancer within the last
5 years excluding non-melanoma skin cancer, serious psychiatric
disorders including dementia, inability to understand the proce-
dures, inability to attend or comply with treatment or follow-up
scheduling and pregnancy.
Altogether,111 (64.0% female) subjects were examinedwithMRI
at the baseline visit and were included. Mean age was 64.4 years
with a median of 64. The age range was from 51 to 81 years. On
average the participants were overweight (mean body mass index
29.3, median 28.2, with a range from 21.3 to 42.7).
The study was approved by the local institutional review board.Radiography
All subjects received weight-bearing conventional radiographs
of both knees according to the semiﬂexed (metatarsophalangeal)
radiographic protocol suggested by Buckland-Wright20. Knee
radiographs were scored by one rheumatologist with 15 years
experience in the assessment of knee OA according to the K/L
grading scheme21.
MRI
At the time of theMRI patients were asked to identify their more
symptomatic knee whenever both knees had evidence of at least
one equivocal osteophyte. 1.5 T MRI of that knee was performed
with a phased array knee coil at baseline using the following pulse
sequence protocol: sagittal non-fs T1-w spin echo, coronal inter-
mediate-weighted fs, axial PD fs, axial T1-w fs CE and a sagittal T1-w
fs CE sequence. For the present study only the axial and sagittal
T1-w fs CE (TR 620 ms, TE 15.8 ms, slice thickness/slice gap 4.0 mm/
0.2 mm, echo train length 2, ﬁeld of view 16.016.0 cm,matrix size
256160, number of signal averages 2) and the axial PD fs
(TR 3,860 ms, TE 32 ms, slice thickness/slice gap 4.0 mm/0.2 mm,
echo train length 10, ﬁeld of view 16.016.0 cm, matrix size
256192, number of signal averages 2) sequenceswere considered.
The CE scanswere acquired beginning 3 min after intra-venous (i.v.)
injection of 0.2 ml (0.1 mmol)/kg body weight Gadodiamide
(Omniscan, GE Healthcare, Little Chalfont, UK). As both CE
sequences required around 4 min scan time, image acquisition of
the CE sequences was performed between 3 min and 11 min after
i.v. contrast injection. Image assessment of enhancement was per-
formed weeks to months after the images were acquired.
Synovial enhancement was scored semi-quantitatively (SQ)
from 0 to 3 according to a recently introduced scoring system by
one MSK radiologist with 8 years experience in standardized SQ
assessment of knee OA19: 0: physiologic enhancement and no
synovial thickening, 1: <2 mm (equivocal synovial thickness),
2: 2e4 mm (moderate synovitis) and 3: >4 mm (severe syno-
vitis). The following 11 articular subregions were assessed: supra-
patellar, infrapatellar, medial parapatellar, lateral parapatellar,
intercondylar, around the anterior cruciate ligament (ACL), poste-
rior to the posterior cruciate ligament (PCL), medial perimeniscal,
lateral perimeniscal, Baker’s cysts and around loose bodies. The
remaining sequences of the MRI examinations were not used or
displayed for the assessment of synovitis and joint effusion and
thus, readers were blinded to these. The reported intra-reader
reliability originally performed on 50 knees by the same expert
reader used in the present study and a second expert MSK radiol-
ogist who is a co-author ranges from 0.67 to 1.00 for the 11 sites19.
Maximum synovial enhancement was consequently grouped as
absent (grade 0), equivocal (grade 1) and deﬁnite (grades 2 and 3).
Joint effusionwas scored from 0 to 3, separately on the PD fs and
T1-w fs CE sequences9,11. Effusion was deﬁned as homogeneous
hyperintensity within the joint cavity on the PD fs images and as
homogeneous intraarticular hypointensity on the T1-w fs CE
images. As the descriptions of effusion scoring are based on non-
enhanced imaging only, we used a visual subtraction method of the
observed amount of capsular distention minus the enhancing
synovium within the distended articular cavity to estimate the
amount of true hypointense ﬂuid-equivalent effusion on the T1-w
FS CE images.
We described the anatomical distribution of synovitis in the
whole sample according to subregions and also by effusion status.
MATLAB R2007a (The MathWorks, Inc., Natick, MA) and Stata
10.0 (StataCorp LP, College Station, TX) software were used to
generate all possible combinations of effusion status and
Fig. 1. Localized synovitis. Sagittal T1-w fs CE image shows marked synovial thick-
ening (grade 3) posterior to the PCL (arrows). Distal PCL depicted as hypointense linear
structure (arrowheads).
Table II
Anatomical distribution of synovitis
Location Synovitis grade (%)
0 1 2 3
sPat 12 (10.8) 33 (29.7) 50 (45.0) 16 (14.4)
iC 29 (26.1) 42 (37.8) 37 (33.3) 3 (2.7)
iPat 38 (34.2) 43 (38.7) 27 (24.3) 3 (2.7)
pmPat 18 (16.2) 43 (38.7) 37 (33.3) 13 (11.7)
plPat 15 (13.5) 42 (37.8) 37 (33.3) 17 (15.3)
Acl 6 (5.4) 52 (46.8) 48 (43.2) 5 (4.5)
Pcl 4 (3.6) 28 (25.2) 56 (50.5) 23 (20.7)
mMen 21 (18.9) 54 (48.6) 33 (29.7) 3 (2.7)
lMen 28 (25.2) 53 (47.7) 25 (22.5) 5 (4.5)
lB* n.a. 2 (25.0) 6 (75.0) n.a.
Bak** 18 (26.9) 32 (47.8) 13 (19.4) 4 (6.0)
* Loose bodies only present in 8/111 knees.
** Baker’s cysts present in 67/111 knees.
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clusters of subregions. Logistic regression was applied to analyze
possible associations between synovitis severity deﬁned by
number of affected sites and radiographic disease severity. Scoring
of effusion on PD fs and T1-w fs CE sequences was also compared by
overall percent agreement and w-kappa statistics.
Results
The baseline K/L grades of examined knees were: K/L 1: 20
knees (18.0%), K/L 2: 42 knees (37.8%), K/L 3: 40 knees (36.0%), K/L
4: 9 knees (8.1%). No knees with K/L grade 0 were included.
Synovitis
99 (89.2%) of knees showed at least one subregion with a syno-
vitis score of 2 or higher and 44 (39.6%) knees exhibited the
maximum score of 3 in at least one subregion. The commonest sites
of deﬁnite synovitis were posterior to the PCL (Fig. 1) in 79 (71.2%)
knees and in the suprapatellar region in 66 (59.5%) knees. The
prevalence of deﬁnite synovitis for the different subregions is
visualized in Table I. The mean number of sites showing any
synovitis was 6.5 (SD 2.2) for those with K/L grade 1, and 7.6 (SD
2.5), 8.8 (SD 1.4) and 9.2 (SD 1.5) for KL grades 2, 3 and 4. The mean
number of affected sites with deﬁnite synovitis was 4.2 (SD 2.8),
with the median being 4 and a range of 0e11. Deﬁnite synovitis in
at least one locationwas present in 96.3% (78/81) of knees with any
effusion and in 70.0% (21/30) of knees without an effusion. TheTable I
Anatomical distribution of deﬁnite synovitis (n¼ 111 knees)
Deﬁnite synovitis* sPat iC iPat pmPat
n (%) 66 (59.5) 40 (36.0) 30 (27.0) 50 (45.0)
Abbreviations: sPate suprapatellar, iCe intercondylar, iPate infrapatellar, pmPate perip
PCL, mMen e perimeniscal medial, lMen e perimensical.
* Deﬁned as synovitis grades 2.anatomical distribution of synovitis for the different subregions
and grades for all knees is presented in Table II.
Using ordinal logistic regression the increasing trend between
the number of subregions with synovitis and the KL grades was
conﬁrmed with an odds ratio of 1.4 (95% conﬁdence interval
1.2e1.7, P< 0.001). However, a moderate and high number of
affected subregions were also seen in knees with early TF OA
(Table III).Effusion
The distribution of the different effusion grades for the PD fs and
the T1-w fs CE sequence is presented in Table IV. Markedly more
knees exhibited a grade 3 effusion on the PD fs sequence when
compared to the T1-w fs CE sequence (32 vs 8). Overall agreement
of effusion scoring on the PD fs and T1-w fs CE sequence was 65.8%.
The weighted kappa comparing agreement between scoring on the
PD fs and T1-w fs CE sequences was 0.70 (95% conﬁdence interval
0.62e0.77). Over-scoring of effusion on the PD fs sequence when
compared to the T1-w fs CE sequence was observed in 37 cases,
over-scoring of T1-w fs CE when compared to the PD fs sequence
was only observed in one case where a grade 1 effusion was scored
on the enhanced images and a grade 0 on the non-enhanced
sequence (Fig. 2). 73.0% of knees showed any effusion on T1-w fs CE
and 37.8% of knees exhibited a grade 2 or 3 effusion on the
enhanced images. When tabulated against KL grades, the mean
score for effusion on the T1-w fs CE images was 0.7 (SD 0.7), 0.9 (SD
0.9), 1.4 (SD 0.8) and 2.4 (SD 0.5) for KL grades 1, 2, 3, and 4
respectively. Using ordinal logistic regression, the increase in the
mean effusion score in association to increasing K/L grade had an
odds ratio of 3.0 (95% conﬁdence interval 2.0e4.6, P< 0.001).Discussion
In a population of mixed radiographic OA severity, we found
that the large majority of knees exhibited deﬁnite synovitis in at
least one subregion and almost half showed severe localizedLocation
plPat Acl Pcl mMen lMen
57 (51.4) 53 (47.7) 79 (71.2) 36 (32.4) 30 (27.0)
atellar medial, plPate peripatellar lateral, Acle around the ACL, Pcle posterior to the
Fig. 2. Joint effusion. (A) Axial PD fs image. Marked bright signal intensity within the
joint and convexity of the joint capsule suggestive of a large joint effusion are depicted
(arrowheads). (B) Axial T1 fs CE image of the same knee at the same slice position. The
CE image shows marked synovial thickening depicted as hyperintense tissue lining
along the joint capsule. Only a small amount of effusion is observed (arrowheads).
Table III
Number of subregions with any synovitis according to radiographic OA status
Number of
subregions with
any synovitis
Radiographic TF OA status
K/L 1
n¼ 20
(18.0%)
K/L2
n¼ 42
(37.8%)
K/L3
n¼ 40
(36.0%)
K/L4
n¼ 9
(8.1%)
Total
n¼ 111
(100%)
2e3 4 (20%) 5 (11.9%) 0 0 9 (8.1%)
4e5 0 3 (7.1%) 1 (2.5%) 0 4 (36.0%)
6e7 8 (40%) 8 (19.0%) 5 (12.5%) 1 (11.1%) 22 (19.8%)
8e9 8 (40%) 15 (35.7) 22 (55%) 3 (33.3%) 48 (43.2%)
10e11 0 11 (26.2%) 12 (30%) 5 (55.6%) 38 (34.2%)
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the PCL, which has not been reported previously and is not included
in other MRI scoring systems5,9,16,22. Surprisingly, also many knees
with early OA showed signs of synovitis in multiple articular
subregions. Synovitis was also observed commonly in knees with
and without concomitant joint effusion. More intraarticular sites
affected by synovitis and higher grades of joint effusion are asso-
ciated with higher grades of radiographic TF OA. Another important
ﬁnding from this study is that that ﬂuid-sensitive MRI sequences
are not able to properly distinguish joint effusion from synovial
thickening and therefore commonly over-report the presence of
effusion.
Several methods for assessing synovitis with non-enhanced and
CE MRI are available2,6,12. However, it seems that using a surrogate
of synovitis on non-enhanced imaging is a very non-speciﬁc
measure of synovitis13. Based on the experience with assessment of
synovitis in rheumatoid arthritis and supported by recent work of
Loeuille et al., SQ assessment of synovitis should probably be per-
formed on T1-w CE images, which is the reason to choose
a comprehensive whole-joint scoring system based on T1-w CE
imaging to assess synovitis in our study4,14,19.
Unfortunately, we were not able to correlate our imaging
ﬁndings with a gold standard such as histology. However,
previous studies conﬁrmed the association of synovial thickening
observed on T1-w CE MRI with histologically proven synovitis
and validated the use of MRI as a non-invasive, sensitive method
for evaluating synovial membrane changes4,14. A drawback is the
missing correlation of our ﬁndings with measures of pain, which
would have gone beyond the scope of this report. Another
shortcoming is the missing information on prior knee trauma.
Knee trauma may lead to an acute inﬂammatory response and is
usually cause of joint effusions. Remote trauma may be a trigger
of secondary intraarticular damage that may result in synovial
activation.
We chose the start of the T1-w fs CE sequence at 3 min after i.v.
contrast administration according to the literature applying static
CE MRI to large joints in OA research5,13,16. As we did not attempt to
investigate the dynamic enhancement over time, there might be
the possibility of over- (due to diffusion of contrastmaterial into the
joint cavity) or under-estimation (due to early start of the
sequence) of the amount of synovitis. Dynamic contrast enhancedTable IV
Joint effusion on non-enhanced and CE imagings
Sequence T1-w fs CE PD fs
0 1 2 3 Total
0 28 2 0 0 30
1 1 24 11 3 39
2 0 0 13 21 34
3 0 0 0 8 8
Total 29 26 24 32 111imaging might play a much greater role when evaluating the effect
of disease-modifying OA drugs over time14,23,24.
The commonest site of deﬁnite synovitis was posterior to the
PCL, a ﬁnding that has not been reported previously. The inter-
condylar notch seems to play an important role for joint integrity.
Around 20% of subjects with knee OA exhibit ACL disruptions
without recalling trauma to the knee joint, which seems to repre-
sent an independent risk factor for consequent cartilage loss25.
Recent work by Stein et al. from the Osteoarthritis Initiative found
a strong association of femoral notch stenosis with prevalent ACL
tears cross-sectionally26. Chronic friction within the notch might
lead to debris and detritus triggering localized periligamentous
synovitis around the ACL and PCL27. Pathology of the PCL and its
relation to disease activity and progression has not been explored
F.W. Roemer et al. / Osteoarthritis and Cartilage 18 (2010) 1269e1274 1273in detail. Localized synovitis has been recognized by several
authors, but to date most of these investigations focused on Hoffa’s
fat pad or the perimeniscal regions5,12,13.
Joint effusion is a reﬂection of synovial activation and often
observed in conjunction with differing grades of synovitis.
Surprisingly, we found that 70% of knees exhibited deﬁnite syno-
vitis in at least one subregion despite absent joint effusion. This
ﬁnding supports that localized synovitis might be more common
than previously thought, but may not necessarily sufﬁce to trigger
relevant joint effusion. In knees without OA an association of
meniscal damage and joint effusion could be shown, although that
study did not explore the role of concomitant localized synovitis28.
A large multicenter study based on ultrasound reported joint
effusion in about 30% without signs of synovitis29. To date only one
study assessed the possible role of CE ultrasound for assessment of
synovitis in knee OA. The authors reported a comparable sensitivity
for the detection of effusion and synovitis in the superior recess of
the knee30. If CEUS yields comparable results concerning whole
knee assessment remains to be proven in future studies. However,
CEUS seems to be suited to track treatment response over time by
evaluating changes in synovial perfusion in selected parts of the
joint as has been shown for rheumatoid arthritis31.
Commonly, joint effusion is assessed SQ on axial ﬂuid-sensitive
images9,11 where ﬂuid-equivalent signal within the joint cavity is
thought to represent effusion. Our results suggest that ﬂuid-
sensitive sequences are not able to properly distinguish between
joint ﬂuid and synovial thickening and that the amount of ﬂuid is
commonly over-estimated as both, joint effusion and synovitis, are
depicted as hyperintense structures not distinguishable from each
other. For this reason some authors suggested a combined score of
assessing joint effusion and synovitis9. As a consequence, we
believe that the amount of joint ﬂuid should ideally be assessed on
T1-w CE sequences whenever possible.
Summarizing our ﬁndings, we found that MRI-assessed deﬁnite
localized synovitis is very common in knees with OA and is also
commonly found in joints without exhibiting concomitant joint
effusion. More severe synovitis, deﬁned by the number of affected
intraarticular sites, and higher grades of joint effusion are associ-
ated with radiographic OA severity in a linear fashion. Joint effusion
seems to be over-estimated on ﬂuid-sensitive MRI sequences as
these cannot distinguish ﬂuid from the synovial membrane and
thus, effusion should be assessed on T1-w CE images whenever
possible. The clinical consequence of synovial enhancement at the
different anatomical sites and its relation to joint effusion and
structural progression needs to be further explored in longitudinal
investigations.
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